tumors of Salivary glands
-
Upload
parizad-vk -
Category
Documents
-
view
224 -
download
1
Transcript of tumors of Salivary glands
-
7/28/2019 tumors of Salivary glands
1/60
-
7/28/2019 tumors of Salivary glands
2/60
-
7/28/2019 tumors of Salivary glands
3/60
1. Benign Neoplasms1.1 Pleomorphic Adenoma
- also known as Mixed Tumor
- most common tumor of the majorand minor salivary glands
- parotid gland 85%
submandibular gland 8%
intraoral minor salivary gland 7%
- constitute about 50% of all intraoralminor salivary gland tumors
-
7/28/2019 tumors of Salivary glands
4/60
Location: hard palate most common
intraoral siteupper lipbuccal mucosa
Age: occurs at any ageprevalent from 4th to 6th decades of life
Gender: males
-
7/28/2019 tumors of Salivary glands
5/60
Clinical features:
- generally mixed tumors are mobile except
in the hard palate
- appear as firm, painless swellings- do not cause ulceration of the overlying
mucosa
- when it arises within the parotid gland,
generally mixed tumors are painless andslow growing and located below the ear
and posterior to the mandible
-
7/28/2019 tumors of Salivary glands
6/60
-
7/28/2019 tumors of Salivary glands
7/60
-
7/28/2019 tumors of Salivary glands
8/60
-
7/28/2019 tumors of Salivary glands
9/60
Gross pathologySmoothWell-demarcatedSolidCystic changesMyxoid stroma
-
7/28/2019 tumors of Salivary glands
10/60
Histopathologic features:
- demonstrate a wide spectrum of
histologic features- pleomorphic patterns and variable ratios
of ductal to myoepithelial cells gave rise to
the other term Pleomorphic Adenoma
-
7/28/2019 tumors of Salivary glands
11/60
-
7/28/2019 tumors of Salivary glands
12/60
Treatment:- Surgical excision treatment of choice
- Enucleation not advisable because ofrisk of recurrence due to extension of
tumor through capsular defects
Prognosis:
- Inadequate removal may result in
recurrence.- With recurrence there is an increase
possibility of malignant transformation
-
7/28/2019 tumors of Salivary glands
13/60
1.2 Monomorphic Adenomas
Classifications (based on histologic
pattern)
1.2.1 Basal Cell Adenoma
- constitute about 1% to 2% of all
salivary gland adenomas
- 70% are found within the parotidgland
-
7/28/2019 tumors of Salivary glands
14/60
Location: in minor salivary glands, mostoccurs in upper lip, followed by the palate,
buccal mucosa, and lower lip
Age: between 35 and 80 years
mean age: 60 years
Gender: male
-
7/28/2019 tumors of Salivary glands
15/60
Clinical features:
- generally slow growing tumor and
painless- clinically distinct on palpation, but it can be
multifocal and multinodular
-
7/28/2019 tumors of Salivary glands
16/60
Histopathological features:- forms of basal cell adenoma
1. solid variety of monomorphicadenoma islands or sheets of
basaloid cells shows palisadingpattern
2. trabecular-tubular form exhibits
trabecular cords of epithelial cells
3. Membranous adenoma grows in anodular fashion with variable-sizedislands of tumor tissue
-
7/28/2019 tumors of Salivary glands
17/60
Solid- Most common- Solid nests oftumor cells- Uniform,hyperchromatic,round nuclei,indistinctcytoplasm- Peripheral nuclearpalisading
-
7/28/2019 tumors of Salivary glands
18/60
Trabecular Cells in elongated
trabecular pattern Vascular stroma
-
7/28/2019 tumors of Salivary glands
19/60
Tubular Multiple duct-likestructures Columnar celllining Vascular stroma
-
7/28/2019 tumors of Salivary glands
20/60
MembranousThick eosinophilic
hyaline membranessurrounding nestsoftumor cellsjigsaw-puzzleappearance
-
7/28/2019 tumors of Salivary glands
21/60
Treatment: Conservative surgical excisionincluding a margin of normaluninvolved tissue
Prognosis: For membranous adenoma,monomorphic adenoma
good prognosis/rarely recur
For membranous form of basal cell
adenoma- has significant rate ofrecurrence
-
7/28/2019 tumors of Salivary glands
22/60
1.2.2 Canalicular Adenoma
Location: upper lip most common
site
Gender: Female
Age: older than 50 years old
-
7/28/2019 tumors of Salivary glands
23/60
Clinical features:
- freely movable
- asymptomatic
- size: from few millimeter to 2 to 3 cm
Histopathologic features: showed bilayer
strands of basaloid cells
- cells are cuboidal to columnar
-
7/28/2019 tumors of Salivary glands
24/60
- Well-circumscribed- Multiple foci-Tubular structures line by columnar or cuboidalcells- Vascular stroma
-
7/28/2019 tumors of Salivary glands
25/60
Treatment:
Surgical excision
- include cuff of clinically
normal tissue
-
7/28/2019 tumors of Salivary glands
26/60
1.2.3 Myoepithelioma- benign salivary gland tumorscomposed entirely of myoepithelialcells called as myoepitheliomas
Location: arises within the parotidgland
Age: 3rd to 9th decade of life
Mean age: 53 years old
-
7/28/2019 tumors of Salivary glands
27/60
Gender: no gender predilection
Clinical features: present as circumscribed
painless masses
Histopathologic features: composed of
either plasmacytoid (20%) or
spindle cells (70)%
-
7/28/2019 tumors of Salivary glands
28/60
Spindle cell- More common-
Parotid- Uniform, centralnuclei- Eosinophilic granular
or fibrillar cytoplasm
-
7/28/2019 tumors of Salivary glands
29/60
Plasmacytoid cell- Polygonal- Eccentric oval nuclei
-
7/28/2019 tumors of Salivary glands
30/60
Treatment: Conservative excision includinga thin rim of surrounding
normal tissue
Prognosis: Excellent
-
7/28/2019 tumors of Salivary glands
31/60
1.2.4 Oncocytoma
- also known as Oxyphilic adenoma
- rare lesion
Location: seen predominantly in the
parotid gland
Age: 6th decade of life
-
7/28/2019 tumors of Salivary glands
32/60
Gender:
Clinical features:
- solid, ovoid encapsulated lesions- less than 5 cm in diameter
- in some cases, bilateral occurrence
may be noted
- rarely seen intraorally
-
7/28/2019 tumors of Salivary glands
33/60
Histopathologic features:
- oncocytoma cells are polyhedral
with granular eosinophiliccytoplasm
- nuclei are centrally placed and are
typically vesicular
-
7/28/2019 tumors of Salivary glands
34/60
Cords of uniformcells and thin fibrousstroma Large polyhedralcells Distinct cellmembrane Granular,eosinophiliccytoplasm Central, round,vesicular nucleus
-
7/28/2019 tumors of Salivary glands
35/60
Treatment: Conservative with superficialparotidectomy
Prognosis: GoodRecurrence is rarely noted
-
7/28/2019 tumors of Salivary glands
36/60
1.2.5 Papillary Cystadenoma Lymphomatosum
- also known as Whartins tumor- accounts approximately 7% of
epithelial neoplasms of salivary gland- intraorally, the lesion is rare- positive correlation with smoking- thought to arise within lymphnodes as a
result of entrapment of salivary gland
elements in early develeopment
-
7/28/2019 tumors of Salivary glands
37/60
Location: majority of the cases occurs
within the parotid gland
Age: between 5th and 8th decades of life
Gender: Male
-
7/28/2019 tumors of Salivary glands
38/60
Clinical features:
- when it occurs in the parotid gland,it is present as doughy to cystic
mass
- encapsulated and has smooth to
lobulated surface and a roundoutline
-
7/28/2019 tumors of Salivary glands
39/60
Histopathologic features:
- presence of numerous cystic spacesof irregular outline contain papillary
projections lined by columnar
eosinophilic cells (oncocytes)
-
7/28/2019 tumors of Salivary glands
40/60
Treatment: Surgical excision
Prognosis: Fair
-
7/28/2019 tumors of Salivary glands
41/60
1.3 Ductal Pappilomas- these rare tumors are thought to
arise within the interlobular and
excretory duct portion of the
salivary gland unit
- 3 types;
1. Sialadenoma papilliferum
2. Inverted ductal papilloma3. Intraductal papilloma
-
7/28/2019 tumors of Salivary glands
42/60
Sialadenoma papilliferum- an unusual benign salivary gland tumor
Location: majority of cases have been
found intraorally- most common sites:
buccal mucosa and palate
Age: between 5th
& 8th
decades of life
Gender: common in male
-
7/28/2019 tumors of Salivary glands
43/60
Clinical features:- usually present as a painless exophytic
papillary lesion
Histopathologic features:
- appears to originate from the superficial
portion of the salivary gland excretory
duct
-
7/28/2019 tumors of Salivary glands
44/60
Treatment: Conservative surgery
Prognosis: Good
-
7/28/2019 tumors of Salivary glands
45/60
Inverted ductal papilloma- a rare entity that presents a nodular
submucosal mass resembling a fibroma
or lipoma
- seen in adult and has equal gender
distribution
- histopatholgically, a marked proliferation
of ductal epithelium is seen subjacent tointact mucosa
-
7/28/2019 tumors of Salivary glands
46/60
1.4 Salivary Lymphoepithelial Lesion- also known as Benign LymphoepithelialLesion (BLEL)
- an uncommon cause of major salivary
gland enlargement- present as a persistent, non-painful, firm,
unilateral or bilateral mass in a major
salivary gland
- histophatologically, presence of denseinfiltrate of lymphocytes and plasma cells
-
7/28/2019 tumors of Salivary glands
47/60
Intraductal papilloma- a rare lesion that arises from a greater
depth within the ductal system
- histopathologically, a single or doublelayer of cuboidal or columnar epithlium
covers several papillary fronds that
project into a duct
- treatment: simple excision- prognosis: fair
-
7/28/2019 tumors of Salivary glands
48/60
1.5 Sjogrens Syndrome- expression of autoimmune process that
results principally in dry eyes
(keratoconjunctivitis sicca) and dry mouth
(xerostomia). Rheumatoid arthritis may
also be seen in this syndrome
Etiology: unknown
-
7/28/2019 tumors of Salivary glands
49/60
Racial predilection: occurs in all ethnic andracial groups
Age: peak age 30 years old
children and teenagers may be
affected
Gender: Female
-
7/28/2019 tumors of Salivary glands
50/60
Clinical features:- chief complaint xerostomia
causing difficulty in speaking
and eating. Greater risk for
dental caries, periodontal
disease and oral candidiasis
- parotid gland enlargement
-
7/28/2019 tumors of Salivary glands
51/60
Histopathologic features: a benignlymphocytic infiltrate replaces majorsalivary gland parynchema
Treatment: Symptomatic treatment- artificial saliva and tears
Preventive oral measures
Prognosis: Complicated by an associationwith malignant transformationto lymphoma
-
7/28/2019 tumors of Salivary glands
52/60
2. Malignant Neoplasm
2.1 Carcinoma Ex-Mixed Tumor
Malignant Mixed Tumor
Metastasizing Mixed Tumor
Carcinoma Ex-Mixed Tumor
- arises in a pre-existing mixed
tumor- metastasis occurs only in the
malignant component
-
7/28/2019 tumors of Salivary glands
53/60
- more common than malignant mixedtumor
Malignant Mixed Tumor
- malignant transformation on bothepithelial and malignant components
Metastasizing Mixed Tumor
- characterized by benign mixed tumorwhich metastasizes while retaining itsbland appearance histologically.
-
7/28/2019 tumors of Salivary glands
54/60
Carcinoma Ex-Mixed Tumor
Location: parotid gland 68%
intraoral minor salivary gland 18%
Age: average age when becomes evident
60 years old
20 years beyond the age noted forbenign mixed tumors
-
7/28/2019 tumors of Salivary glands
55/60
Clinical features:- fixation of the mass surrounding thetissues
- ulceration
- regional lymphadenopathy
Treatment: Surgical with radical neckdissection
Prognosis: Fair to Good
-
7/28/2019 tumors of Salivary glands
56/60
2.2 Adenoid Cystic Carcinoma
- 23% of all salivary gland carcinomas
- a high-grade malignancy that has fair 5-
year survival rate but a dismal 15-year
survival rate
-
7/28/2019 tumors of Salivary glands
57/60
Location: 50% to 70% occurs in minor
salivary gland of the head
and neck
- parotid gland is the most affected
major salivary gland
Age: 5th to 7th decades of life
Gender: no gender predilection
-
7/28/2019 tumors of Salivary glands
58/60
Clinical features:- usually unilobular mass which is
firm on palpation
- occasionally with some pain
- characterized by slow growth rate
- present for several years before the
patient seek treatment
- facial nerve weakness or paralysismay occur
- bone invasion may occur
-
7/28/2019 tumors of Salivary glands
59/60
- distant spread to the lungs is morecommon than metastasis to regional
lymph nodes
- intraoral lesions
- palate ulceration of the mucosa
- help to distinguish this
lesion from benign mixed
tumor
-
7/28/2019 tumors of Salivary glands
60/60
Histopathologic features:- ductal structures are lined by
cuboidal cells with uniform nuclei
Treatment: Surgery / Radiation
Wide resection when parotid
gland is involved
Prognosis: 15-20 years survival rate